Ampersand Capital
Overview
Ampersand Capital Partners is a middle-market private equity firm dedicated to growth-oriented investments in the healthcare sector. With offices in Boston, MA, and Amsterdam, Netherlands, Ampersand leverages a unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams. The firm specializes in the “picks and shovels” of healthcare, partnering with companies that provide mission-critical tools and services to life sciences innovators developing breakthrough medicines and medical devices.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Vernal Biosciences | Jun 2023 | Series A Extension | Lead |
For institutional investors. Book with your work email.
Key People
Matthew Norton
General Partner
Patrick Walsh
Operating Partner
Marina Pellón-Consunji
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Ampersand Capital based?
Ampersand Capital is headquartered in Boston, Massachusetts, United States.
When was Ampersand Capital founded?
Ampersand Capital was founded in 1988.
How many portfolio companies does Ampersand Capital have?
Ampersand Capital has 2 portfolio companies in Caplight's dataset.
What are some companies in Ampersand Capital's portfolio?
Portfolio companies visible on Caplight include Vernal Biosciences.
What was Ampersand Capital's most recent investment shown here?
Ampersand Capital's most recent investment in this portfolio sample was in Vernal Biosciences in 2023.
What sectors does Ampersand Capital focus on?
Ampersand Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Ampersand Capital focus on?
Ampersand Capital typically invests at the Early stage.